BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16564944)

  • 1. Understanding the basic case-mix adjustment for the composite rate.
    Wheeler JR; Messana JM; Turenne MN; Hirth RA; Pozniak AS; Pan Q; Chuang CC; Slish K; Tedeschi P; Roys EC; Wolfe RA
    Am J Kidney Dis; 2006 Apr; 47(4):666-71. PubMed ID: 16564944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic impact of case-mix adjusting the dialysis composite rate.
    Hirth RA; Roys EC; Wheeler JR; Messana JM; Turenne MN; Saran R; Pozniak AS; Wolfe RA
    J Am Soc Nephrol; 2005 May; 16(5):1172-6. PubMed ID: 15800122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-mix adjustment for an expanded renal prospective payment system.
    Hirth RA; Turenne MN; Wheeler JR; Pozniak AS; Tedeschi P; Chuang CC; Pan Q; Slish K; Messana JM
    J Am Soc Nephrol; 2007 Sep; 18(9):2565-74. PubMed ID: 17675667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using knowledge of multiple levels of variation in care to target performance incentives to providers.
    Turenne MN; Hirth RA; Pan Q; Wolfe RA; Messana JM; Wheeler JR
    Med Care; 2008 Feb; 46(2):120-6. PubMed ID: 18219239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is case-mix adjustment necessary for an expanded dialysis bundle?
    Hirth RA; Wolfe RA; Wheeler JR; Roys EC; Tedeschi PJ; Pozniak AS; Wright GT
    Health Care Financ Rev; 2003; 24(4):77-88. PubMed ID: 14628401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The costs of dialysis in the USA.
    Garella S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():10-21. PubMed ID: 9075223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case mix in end-stage renal disease. Differences between patients in hospital-based and free-standing treatment facilities.
    Plough AL; Salem SR; Shwartz M; Weller JM; Ferguson CW
    N Engl J Med; 1984 May; 310(22):1432-6. PubMed ID: 6425690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Projected impact of the proposed "bundled" ESRD payment system on a small dialysis organization.
    Bhat P; Sokolowski W; Bhat JG
    Nephrol News Issues; 2009 Jun; 23(7):46, 48-52. PubMed ID: 19585810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-mix adjusted composite rate--did Medicare get it right?
    Messana A
    Nephrol News Issues; 2005 Sep; 19(10):44. PubMed ID: 16187647
    [No Abstract]   [Full Text] [Related]  

  • 10. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG
    N Engl J Med; 1993 Nov; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract]   [Full Text] [Related]  

  • 11. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis.
    Hornberger J; Hirth RA
    Am J Kidney Dis; 2012 Aug; 60(2):280-7. PubMed ID: 22560829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
    Charytan C
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers.
    Schon D; Blume SW; Niebauer K; Hollenbeak CS; de Lissovoy G
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):268-76. PubMed ID: 17699424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prevalence of patient case-mix adjusters used in the Medicare dialysis payment system.
    Hollenbeak CS; Rubin RJ; Tzivelekis S; Stephens JM
    Nephrol News Issues; 2015 Jun; 29(6):24-7, 31-4. PubMed ID: 26237942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database.
    Hutchison CA; Crowe AV; Stevens PE; Harrison DA; Lipkin GW
    Crit Care; 2007; 11(2):R50. PubMed ID: 17451605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the medicare ESRD program pay for daily dialysis? An ethical analysis.
    Anantharaman P; Moss AH
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):290-6. PubMed ID: 17603984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KI study: older patients with CKD are costly as they transition to dialysis.
    St Peter W
    Nephrol News Issues; 2004 Oct; 18(11):85. PubMed ID: 15551617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.